147 related articles for article (PubMed ID: 2898211)
1. Production of transforming growth factor-beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth.
Newcom SR; Kadin ME; Ansari AA
Am J Pathol; 1988 Jun; 131(3):569-77. PubMed ID: 2898211
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing antibodies against transforming growth factor beta potentiate the proliferation of Ki-1 positive lymphoma cells. Further evidence for negative autocrine regulation by transforming growth factor beta.
Newcom SR; Tagra KK; Kadin ME
Am J Pathol; 1992 Mar; 140(3):709-18. PubMed ID: 1312308
[TBL] [Abstract][Full Text] [Related]
3. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.
Kehrl JH; Roberts AB; Wakefield LM; Jakowlew S; Sporn MB; Fauci AS
J Immunol; 1986 Dec; 137(12):3855-60. PubMed ID: 2878044
[TBL] [Abstract][Full Text] [Related]
5. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.
Kehrl JH; Wakefield LM; Roberts AB; Jakowlew S; Alvarez-Mon M; Derynck R; Sporn MB; Fauci AS
J Exp Med; 1986 May; 163(5):1037-50. PubMed ID: 2871125
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.
Sing GK; Ruscetti FW; Beckwith M; Keller JR; Ellingsworth L; Urba WJ; Longo DL
Cell Growth Differ; 1990 Nov; 1(11):549-57. PubMed ID: 1965139
[TBL] [Abstract][Full Text] [Related]
7. L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH.
Newcom SR; Kadin ME; Ansari AA; Diehl V
J Clin Invest; 1988 Dec; 82(6):1915-21. PubMed ID: 2904450
[TBL] [Abstract][Full Text] [Related]
8. Loss of receptors for transforming growth factor beta in human T-cell malignancies.
Kadin ME; Cavaille-Coll MW; Gertz R; Massagué J; Cheifetz S; George D
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6002-6. PubMed ID: 8016105
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
Hsu SM; Xie SS; Hsu PL; Waldron JA
Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.
Kadin ME; Agnarsson BA; Ellingsworth LR; Newcom SR
Am J Pathol; 1990 Jun; 136(6):1209-14. PubMed ID: 2356855
[TBL] [Abstract][Full Text] [Related]
11. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
[TBL] [Abstract][Full Text] [Related]
12. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
Hébert CD; Birnbaum LS
Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
[TBL] [Abstract][Full Text] [Related]
13. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
14. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
[TBL] [Abstract][Full Text] [Related]
15. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
Kumar A; Rogers T; Maizel A; Sharma S
J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611
[TBL] [Abstract][Full Text] [Related]
16. Expression of growth factor/receptor genes in postthymic T cell malignancies.
Su IJ; Kadin ME
Am J Pathol; 1989 Sep; 135(3):439-45. PubMed ID: 2789474
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation.
Wahl SM; Hunt DA; Wong HL; Dougherty S; McCartney-Francis N; Wahl LM; Ellingsworth L; Schmidt JA; Hall G; Roberts AB
J Immunol; 1988 May; 140(9):3026-32. PubMed ID: 3129508
[TBL] [Abstract][Full Text] [Related]
18. Cytokines in malignant lymphomas: review and prospective evaluation.
Hsu SM; Waldron JW; Hsu PL; Hough AJ
Hum Pathol; 1993 Oct; 24(10):1040-57. PubMed ID: 8406414
[TBL] [Abstract][Full Text] [Related]
19. Expression of p55 (Tac) interleukin-2 receptor (IL-2R), but not p75 IL-2R, in cultured H-RS cells and H-RS cells in tissues.
Hsu SM; Tseng CK; Hsu PL
Am J Pathol; 1990 Apr; 136(4):735-44. PubMed ID: 1691591
[TBL] [Abstract][Full Text] [Related]
20. Growth regulation of simian and human AIDS-related non-Hodgkin's lymphoma cell lines by TGF-beta1 and IL-6.
Ruff KR; Puetter A; Levy LS
BMC Cancer; 2007 Feb; 7():35. PubMed ID: 17324269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
